Author:
Uma Devi Karuru,Sadanand Reddy Tummala,Naveen T,Kiran Kumar Kanjerla,Gautam PS,Sai Kumar Mysore
Abstract
Rheumatic heart disease persists as a significant concern in developing regions, often resulting in multivalvular heart conditions. Treatment options are limited, though percutaneous transvenous mitral commissurotomy effectively addresses rheumatic mitral stenosis. Non-surgical interventions for aortic stenosis include balloon aortic valvotomy and Transcatheter aortic valve replacement (TAVR), tailored to patient factors like age and comorbidities. We describe two cases of Rheumatic multivalvular disease which were managed non-surgical. The first case is a pioneering procedure performed on a young patient combined percutaneous transvenous mitral commissurotomy with balloon aortic valvotomy, guided by 4-dimensional transoesophageal echocardiography (4D TEE). This represents the first documented instance in medical literature, showcasing the potential of integrated interventions and advanced imaging techniques. In the second challenging case involving a heavily calcified, retrovirus, and Hepatitis B positive 55-year-old, a staged approach was adopted, involving percutaneous transvenous mitral commissurotomy followed by Transcatheter aortic valve replacement (TAVR). Despite complexities, this sequential strategy demonstrates the adaptability of transcatheter techniques in managing complex valvular pathologies. These cases highlight the evolving landscape of interventional cardiology and underscore the importance of tailored, multidisciplinary approaches in optimizing outcomes for patients with rheumatic heart disease and multivalvular involvement, especially in resource-limited settings. Further exploration and dissemination of such innovative strategies hold promise for enhancing cardiac care quality and expanding treatment options globally.
Publisher
Heighten Science Publications Corporation
Reference13 articles.
1. 1. The Society of Thoracic Surgeons Adult Cardiac Surgery Database: 2022 Update on Outcomes and Research. Kim, Karen M. et al. The Annals of Thoracic Surgery, 2022; 115(3):566 - 574
2. 2. Wilkins GT, Weyman AE, Abascal VM, Block PC, Palacios IF. Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J. 1988 Oct;60(4):299-308. doi: 10.1136/hrt.60.4.299. PMID: 3190958; PMCID: PMC1216577.
3. 3. Alkatiri AA, Yamanaka F, Shishido K, Moriyama N, Ochiai T, Noguchi K, Firman D, Soerianata S, Saito S. Percutaneous transvenous mitral commissurotomy and transcatheter aortic valve replacement for rheumatic mitral and aortic stenosis. J Cardiol Cases. 2022 Aug 18;26(5):357-359. doi: 10.1016/j.jccase.2022.07.010. PMID: 36312777; PMCID: PMC9605916.
4. 4. Bilge M, Alsancak Y, Ali S, Yasar AS. Concurrent Transcatheter Aortic Valve Implantation and Percutaneous Transvenous Mitral Commissurotomy for Totally Percutaneous Treatment of Combined Severe Rheumatic Aortic and Mitral Stenosis. J Heart Valve Dis. 2015 May;24(3):286-9. PMID: 26901896.
5. 5. Mechmeche R, Cherif A, Elmnouchi R. Dilatation percutanee d'un double retrecissement mitral et aortique d'origine rhumatismale [Percutaneous balloon valvotomy for combined rheumatic mitral and aortic stenosis]. Tunis Med. 2008 Jun;86(6):598-9. French. PMID: 19216456.